ALEXANDRIA, Va., April 2 -- United States Patent no. 12,264,137, issued on April 1, was assigned to VALO HEALTH INC. (Boston).

"3-aryl-4-amido-bicyclic [4,5,0 hydroxamic acids as HDAC inhibitors" was invented by Xiaozhang Zheng (Lexington, Mass.), Pui Yee Ng (Lexington, Mass.), Bingsong Han (Westwood, Mass.), Jennifer R. Thomason (Clinton, Mass.), Mary-Margaret Zablocki (Revere, Mass.), Cuixian Liu (Madison, Conn.), Aleksandra Rudnitskaya (Roslindale, Mass.), David R. Lancia Jr. (Boston), David S. Millan (Watertown, Mass.) and Matthew W. Martin (Arlington, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to inhibitors of zinc-dependent histone deacetylases (HDACs) useful in...